Dr. Oz has extolled Ozempic’s promise for weight-loss. Now Medicare, which Trump wants Oz to oversee, may cover it.

Jaguar's rebranding marks a radical identity shift for the carmaker. One ad expert called it "bonkers." Others said it was a ...

It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...

We recently compiled a list of the Louis Navellier’s Top 10 Stock Picks Heading into 2025. In this article, we are going to ...

The biotech industry can be volatile even for relatively large companies. Amgen ( AMGN 1.00%), one of the more prominent names in the game, just reminded us all of that fact. On Nov. 26, the company's ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Now, Lilly Downs is living life outside the hospital’s walls, on her own for the first time, traveling with friends to Utah, ...

Indiana’s first-half summit would come later in the first quarter when the Hoosiers led 19-8, but Maine didn’t panic. The ...

Lilly is ready for the holidays in the Village of Pine Ridge. We’d love to see your Christmas decorations and your dressed-up pets. Send your submission to [email protected] ...